Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Radiation and Chemotherapy

ClinicalTrials.gov ID: NCT02542215

Public ClinicalTrials.gov record NCT02542215. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 6:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy, Safety, and Pharmacokinetics of Cobiprostone for the Prevention of Severe Oral Mucositis in Subjects With Head and Neck Cancer (HNC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Treatment for head and neck cancer often involves a combination of chemotherapy and radiation. One of the unfortunate consequences of standard care for head and neck cancer is the development of painful mouth sores, known as oral mucositis. This study will evaluate the use of cobiprostone spray to prevent oral mucositis, when given for the duration of radiation and chemotherapy (RT/CT) standard care.

Study identification

NCT ID
NCT02542215
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sucampo Pharma Americas, LLC
Industry
Enrollment
47 participants

Conditions and interventions

Conditions

Interventions

Drug · Radiation

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2015 (Type not available)
Primary completion
Jul 2016 (Actual)
Completion
Jul 2016 (Actual)
Last update posted
Dec 2, 2019

2015 – 2016

United States locations

U.S. sites
76
U.S. states
35
U.S. cities
75
Facility City State ZIP Site status
Investigational Site Birmingham Alabama 35294 —
Investigational Site Peoria Arizona 85381 —
Investigational Site Yuma Arizona 85364 —
Investigational Site Little Rock Arkansas 72205 —
Investigational Site Duarte California 91010 —
Investigational Site Fullerton California 92835 —
Investigational Site Los Angeles California 90048 —
Investigational Site Montebello California 90640 —
Investigational Site Oceanside California 92056 —
Investigational Site Redondo Beach California 90277 —
Investigational Site San Francisco California 94115 —
Investigational Site Whittier California 90603 —
Investigational Site Denver Colorado 80210 —
Investigational Site Farmington Connecticut 06030 —
Investigational Site Fort Lauderdale Florida 33316 —
Investigational Site Fort Myers Florida 33908 —
Investigational Site Lakeland Florida 33805 —
Investigational Site Miami Beach Florida 33140 —
Investigational Site Naples Florida 34102 —
Investigational Site Plantation Florida 33322 —
Investigational Site Stuart Florida 34994 —
Investigational Site Winter Haven Florida 33880 —
Investigational Site Boise Idaho 83706 —
Investigational Site Urbana Illinois 61801 —
Investigational Site Fort Wayne Indiana 46845 —
Investigational Site South Bend Indiana 46601 —
Investigational Site Topeka Kansas 66606 —
Investigational Site Ashland Kentucky 41101 —
Investigational Site Baton Rouge Louisiana 70809 —
Investigational Site Metairie Louisiana 70006 —
Investigational Site New Orleans Louisiana 70112 —
Investigational Site Shreveport Louisiana 71103 —
Investigational Site Baltimore Maryland 21201 —
Investigational Site Bethesda Maryland 20889 —
Investigational Site Burlington Massachusetts 01805 —
Investigational Site Ann Arbor Michigan 48109 —
Investigational Site Detroit Michigan 48201 —
Investigational Site East Lansing Michigan 48867 —
Investigational Site Minneapolis Minnesota 55417 —
Investigational Site St Louis Missouri 63110 —
Investigational Site Billings Montana 59101 —
Investigational Site Omaha Nebraska 68198 —
Investigational Site Reno Nevada 89502 —
Investigational Site Egg Harbor New Jersey 08234 —
Investigational Site New Brunswick New Jersey 08901 —
Investigational Site Charlotte North Carolina 28203 —
Investigational Site Gastonia North Carolina 28054 —
Investigational Site Greenville North Carolina 27834 —
Investigational Site Canton Ohio 44718 —
Investigational Site Sylvania Ohio 43560 —
Investigational Site Oklahoma City Oklahoma 73104 —
Investigational Site Coos Bay Oregon 97420 —
Investigational Site Corvallis Oregon 97330 —
Investigational Site Portland Oregon 97227 —
Investigational Site Gettysburg Pennsylvania 17325 —
Investigational Site Hershey Pennsylvania 17033 —
Investigational Site Natrona Heights Pennsylvania 15065 —
Investigational Site Philadelphia Pennsylvania 19104 —
Investigational Site Pittsburgh Pennsylvania 15232 —
Investigational Site State College Pennsylvania 16801 —
Investigational Site Pawtucket Rhode Island 02860 —
Investigational Site Myrtle Beach South Carolina 29577 —
Investigational Site Cookeville Tennessee 38501 —
Investigational Site Austin Texas 78701 —
Investigational Site Fort Sam Houston Texas 78234 —
Investigational Site Galveston Texas 77555 —
Investigational Site Houston Texas 77030 —
Investigational Site Houston Texas 77089 —
Investigational Site Temple Texas 76508 —
Investigational Site Charlottesville Virginia 22911 —
Investigational Site Fort Belvoir Virginia 22060 —
Investigational Site Bellingham Washington 98225 —
Investigational Site Everett Washington 98201 —
Investigational Site Seattle Washington 98101 —
Investigational Site Morgantown West Virginia 26506 —
Investigational Site Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02542215, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 2, 2019 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02542215 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →